Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Males and females~* Acute ischemic stroke with limb weakness, onset of symptoms within 6 hours~* Full functional independence prior to the present stroke~Exclusion Criteria:~* Unconsciousness~* Subjects who are unlikely to complete the infusion of investigational product and/or are unlikely to undergo active medical management during that period due to a severe clinical condition~* Severe illness with life expectancy less than 6 months~* Known severe kidney disorder~* Current known alcohol or illicit drug abuse or dependence~* Pregnant or breast-feeding~* Treatment with acetazolamide and methotrexate is not permitted during the infusion~* Participation in a previous clinical study within 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).